SEC Form 4 · accession 0001209191-15-069951
Vanda Pharmaceuticals Inc. · VNDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gian Piero Reverberi
Officer — SVP, General Manager Europe
Period of report
Sep 8, 2015
Accepted (ET)
Sep 9, 2015 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347178
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $12.68 | Sep 8, 2015 | A | 150,000 | A | — | Sep 7, 2025 | Common Stock | 150,000 | 150,000 | D |
| Restricted Stock UnitF2,F3,F4 | — | Sep 8, 2015 | A | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This option vests and becomes exercisable with respect to 1/4 of the shares subject to this option on September 8, 2016 (the "Initial Vesting Date"), provided Reporting Person remains continuously employed by the Issuer through the Initial Vesting Date, and with respect to the remaining 3/4 of the shares in 36 equal monthly installments beginning on October 8, 2016, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
- F2Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- F3The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- F4Not applicable.